A9542 HCPCS code: Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries

A9542 is the HCPCS Level II code for indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1 per day on outpatient hospital claims.

Code details

FieldValue
SectionA codes — Transportation, medical/surgical supplies and miscellaneous
Coverage codeC — Carrier judgment
Pricing indicator51 — Drug or biological (priced per ASP/average sales price rules)
BETOS categoryI1E
Added2006-01-01
Last action effective2025-01-01

NCCI unit limits (MUE)

Claim typeMax units per dayRationale
outpatient hospital claims1Code Descriptor / CPT Instruction
practitioner claims1Code Descriptor / CPT Instruction

What changed for A9542

Frequently asked questions

What is HCPCS code A9542?

A9542 is the HCPCS Level II code for indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries. Short descriptor: "In111 ibritumomab, dx".

Does Medicare cover A9542?

Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.

How many units of A9542 can be billed per day?

1 on outpatient hospital claims; 1 on practitioner claims (NCCI medically unlikely edits).

Related A95 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.

All A codes · HCPCS lookup